Monica Montes

USPTO Granted Patents = 6 (Patent Applications = 2)

CIPO Patents = 3 (Patent Applications = 1)

EPO Patents = 6 (Patent Applications = 8)

Average Co-Inventor Count = 5.3

ph-index = 5

Forward Citations = 123(Granted Patents)

Company Filing History:

6 out of 93

Baylor Research Institute

patents

1 out of 1

Agence Nationale De Recherches Sur Le Sida Et Les Hepatitis Virales

patent

where one patent can have more than one assignee

Years Active: 2013-2021

Loading Chart...

6 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10988544 - Fusion proteins comprising an anti-CD40 antibody and HIV antigenic peptides (2021-04-27),

2. 9862927 - Dendritic cell vaccines (2018-01-09),

3. 9416186 - Antigen presenting cell targeted anti-viral vaccines (2016-08-16),

4. 9109011 - Dendritic cell-specific antibody conjugate comprising anti-CD40 monoclonal antibodies conjugated to HIV-1 Gag/Nef (2015-08-18),

5. 8961991 - Anti-CD40 targeted fusion proteins (2015-02-24),

6. 8518410 - Fusion protein with HIV antigen (2013-08-27),

Title: Inventor Monica Montes: Pioneering Innovations in Dallas

Introduction: Monica Montes is a visionary inventor based in Dallas, Texas, known for her groundbreaking contributions to various industries.

Latest Patents: Monica Montes holds several patents in the fields of technology, healthcare, and sustainability, showcasing her diverse range of expertise.

Career Highlights: With a career spanning over two decades, Monica Montes has consistently pushed the boundaries of innovation, leading to significant advancements in her areas of focus.

Collaborations: Throughout her career, Monica Montes has collaborated with leading researchers, engineers, and companies to bring her inventions to life, fostering a culture of innovation and creativity.

Conclusion: Monica Montes continues to inspire the next generation of inventors with her passion for creating solutions that make a positive impact on society.

This text is generated by artificial intelligence and may not be accurate.